PLOS Aging and Health · Nov 17, 2026
Electroretinography for characterizing retinal dysfunction in Alzheimer’s disease and related dementias in older adults: A scoping review
By Duah IO, Houston KJ, Rodriguez D et al.
Electroretinography (ERG) captures retinal electrical activity and may provide a non-invasive window into neurodegenerative processes in Alzheimer’s disease and related dementias (ADRD). This scoping review characterized ERG abnormalities in ADRD, examined associations with cognitive and pathological measures, and identified priorities for clinical translation. Eight databases were searched from inception until February 1, 2026, without language restrictions. Two authors independently screened studies, and three reviewers independently extracted data in Covidence from eligible studies involving adults aged ≥50 years that evaluated ERG in ADRD or normal ageing. Out of the 2,777 records identified, 26 studies met the eligibility criteria; although no language restrictions were applied, all eligible articles were published in English. Most studies used comparative cross-sectional designs (n = 19). Pattern ERG (pERG) was the sole modality in 12 studies, followed by full-field ERG (ffERG; n = 7) and multifocal ERG (mfERG; n = 2). One study used high-frequency ERG (HF-ERG), while four combined multiple modalities. Twenty-three studies utilized non-portable and three investigations used portable ERG systems. Full-field ERG findings showed reduced a- and b-wave amplitudes, lower photopic negative response-to-b-wave ratios, and prolonged implicit times. Pattern and multifocal ERG also revealed attenuated amplitudes or delayed retinal latency. Associations between ERG and cognition were modest and selective; prolonged ERG latencies correlated with lower Mini-Mental State Examination scores and greater amyloid burden in some studies. ERG findings indicate neuroretinal functional alterations in ADRD, although their magnitude and consistency vary across studies. Modest associations with cognition and limitations, including small samples, cross-sectional designs, heterogeneous protocols, limited molecular biomarker confirmation, and inadequately addressed ocular confounders preclude firm conclusions about diagnostic or prognostic utility. Altogether, prospective longitudinal studies using standardized protocols and integrating ERG with cognitive, neuroimaging, and molecular measures are needed to establish its clinical relevance.